US00547W3079 - Common Stock
DMK PHARMACEUTICALS CORP
NASDAQ:DMK (2/6/2024, 8:05:16 PM)
After market: 0.1665 -0.07 (-28.23%)0.232
+0 (+0.91%)
Adamis Pharmaceuticals Corp. is a biopharmaceutical company, which engages in the discovery, development, and sale of pharmaceutical, specialty biopharmaceutical, and other drug products. The company is headquartered in San Diego, California and currently employs 11 full-time employees. The firm is focused on developing therapies for opioid use disorder (OUD) and other neuro-based conditions. The Company’s commercial products approved by the United States Food and Drug Administration (FDA) include ZIMHI (naloxone) injection for the treatment of opioid overdose, and SYMJEPI (epinephrine) Injection for use in the emergency treatment of acute allergic reactions, including anaphylaxis. The company has a library of approximately 750 small molecule neuropeptide analogues and a differentiated pipeline. The Company’s lead clinical-stage product candidate, DPI-125, is being studied as a treatment for OUD. The Company’s other development stage product candidates include DPI-221 for bladder control problems and DPI-289 for severe end stage Parkinson’s disease.
DMK PHARMACEUTICALS CORP
11682 El Camino Real, Suite 300
San Diego CALIFORNIA
P: 18589972400
Employees: 11
Website: https://www.dmkpharmaceuticals.com/
The biggest pre-market stock movers are starting off the trading week as we check out all of the hottest news for Monday morning!
DMK Pharmaceuticals files for Chapter 11 bankruptcy, expecting court approval. Pre-market stock falls by 20.90%.
Pre-market stock movers are a hot topic this morning as we check out all of the winners and losers worth keeping tabs on for Thursday!
Company seeking commercialization partnerships in the United States, Canada, and Europe to expand revenue generation...
Now seeking out license opportunities for SYMJEPI®...
Here you can normally see the latest stock twits on DMK, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.
Example Twits: